Officials with the American Academy of Pediatrics stress that there’s no need for alarm but they do urge that more data be collected concerning children and COVID-19 infection, and they also note that there’s still no vaccine for youngsters 5–12.
A joint report by the American Academy of Pediatrics (AAP) and the Children’s Hospital Association indicates that 243,373 children were infected with COVID-19 from September 2 to September 9, 2021. From August 26 to September 9, 2021, there was a 10% increase in reported cases for children.1 (The definition of “child” varies from state to state but in all 49 states reporting, the age starts at 0 years. The higher-end cutoff age varies and can be anywhere from 14 to 20 years.) Children represent 15.5% of all cases in the pandemic up until this point. At present, there are no vaccines for children aged 5 to 12 years.
“At this time, it appears that severe illness due to COVID-19 is uncommon among children,” the AAP stated in a press release about the study.2 “However, there is an urgent need to collect more data on longer-term impacts of the pandemic on children, including ways the virus may harm the long-term physical health of infected children, as well as its emotional and mental health effects.”
In the 11 states reporting testing, children made up from 11.1% to 21.6% of the total cumulated tests, which showed that from 4.9% to 17.8% of children tested positive. Twenty-four states reported hospitalizations, and children accounted for 1.6% to 4% of the total cumulated hospitalizations.
Pediatricians are especially keeping a close eye on multisystem inflammatory syndrome in children, or MIS-C. According to the Centers for Disease Control and Prevention (CDC), MIS-C, “is a condition[in which] different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.” The CDC admits that it does not “yet know what causes MIS-C. However, many children with MIS-C had the virus that causes COVID-19 or had been around someone with COVID-19.”
Linda Spaulding, RN-BC, CIC, CHEC, CHOP, a member of Infection Control Today®’sEditorial Advisory Board, warns that it’s a mistake to underestimate the harm COVID-19 can do to younger people.
“People keep [saying], ‘Well, the young kids [will] get it. They’ll get over it. It’s no big deal.’ But that’s not the reality of it. There are many young kids that have got COVID-19 and are now dealing with what they’re calling long-haulers disorder. And that’s when they do have heart damage or they have lung damage.”
She added that the disease “can be fatal in kids.”
References:
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.